Fedha

Hisa unazofuatilia
600535:SHA
Tasly Pharmaceutical Group Co Ltd
CN¥ 14.04
-0.35%
(-0.050) Siku 1
16 Okt, 15:00:00 GMT +8  ·   CNY
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 600535...
Fungua
CN¥ 14.18
Juu
CN¥ 14.35
Chini
CN¥ 13.92
Mtaji wa soko
20.87B
Wastani wa kiasi cha mauzo
11.45M
Kiasi cha mauzo ya hisa
15.72M
Gawio
2.42%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.09
Tarehe ya kutojumuisha gawio
29 Mei 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
17.15
Juu kwa wiki 52
CN¥ 16.24
Chini kwa wiki 52
CN¥ 12.90
EPS
CN¥ 0.82
Hisa za wawekezaji
1.51B
Idadi ya wafanyakazi
elfu 11
Fungua
CN¥ 14.18
Juu
CN¥ 14.35
Chini
CN¥ 13.92
Mtaji wa soko
20.87B
Wastani wa kiasi cha mauzo
11.45M
Kiasi cha mauzo ya hisa
15.72M
Gawio
2.42%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.09
Tarehe ya kutojumuisha gawio
29 Mei 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
17.15
Juu kwa wiki 52
CN¥ 16.24
Chini kwa wiki 52
CN¥ 12.90
EPS
CN¥ 0.82
Hisa za wawekezaji
1.51B
Idadi ya wafanyakazi
elfu 11
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines. It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange. In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation. In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Kuhusu Tasly Pharmaceutical Group Co Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 10.6
Lilianzishwa1994
Makao makuu-
Sekta-
Tovutitasly.com
Ripoti za awaliThamani zote katika CNY
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika CNY
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
2.02B
1.93B
2.16B
2.04B
Gharama ya bidhaa zilizouzwa
684.07M
659.71M
623.69M
654.28M
Gharama ya mapato
684.07M
659.71M
623.69M
654.28M
Gharama za utafiti na maendeleo
210.48M
132.23M
191.62M
102.48M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
844.05M
787.37M
874.15M
656.33M
Gharama ya uendeshaji
1.06B
979.15M
1.08B
801.23M
Jumla ya gharama za uendeshaji
1.74B
1.64B
1.70B
1.46B
Mapato ya uendeshaji
281.20M
286.94M
462.71M
580.75M
Mapato mengine yasiyo ya uendeshaji
-7.57M
-6.11M
elfu -733.75
elfu -232.24
EBT ikijumuisha vipengee visivyo vya kawaida
248.13M
192.46M
461.52M
584.82M
EBT bila kujumuisha vipengee visivyo vya kawaida
280.97M
289.16M
472.69M
588.33M
Gharama ya kodi ya mapato
45.36M
123.68M
96.97M
64.84M
Kiwango cha kodi kinachotumika
18.28%
64.26%
21.01%
11.09%
Gharama nyingine za uendeshaji
1.56M
53.20M
17.23M
42.82M
Mapato halisi
209.68M
120.59M
370.24M
522.44M
Kiwango cha faida halisi
10.37%
6.26%
17.10%
25.66%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
14.77M
14.84M
14.04M
11.58M
Gharama ya riba
-7.28M
-5.44M
-3.33M
-5.30M
Jumla ya gharama halisi za riba
7.49M
9.39M
10.71M
6.29M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
380.28M
380.23M
555.99M
663.57M
Faida au hasara kutokana na uuzaji wa vipengee
5.21M
-8.61M
-
elfu -409.04
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google